II 

118TH CONGRESS 

2D SESSION S. 4246 

To improve menopause care and mid-life women’s health, and for other 

purposes. 

IN THE SENATE OF THE UNITED STATES 

MAY 2, 2024 

Mrs. MURRAY (for herself, Ms. MURKOWSKI, Ms. BALDWIN, Ms. COLLINS, 

Ms. KLOBUCHAR, Mrs. CAPITO, Ms. CANTWELL, Ms. CORTEZ MASTO, 

Ms. DUCKWORTH, Mrs. GILLIBRAND, Ms. HASSAN, Ms. HIRONO, Ms. 

ROSEN, Mrs. SHAHEEN, Ms. SINEMA, Ms. SMITH, and Ms. STABENOW) 

introduced the following bill; which was read twice and referred to the 

Committee on Health, Education, Labor, and Pensions 

A BILL 

To improve menopause care and mid-life women’s health, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 

4 (a) SHORT TITLE.—This Act may be cited as the 

5 ‘‘Advancing Menopause Care and Mid-Life Women’s 

6 Health Act’’. 

7 (b) TABLE OF CONTENTS.—The table of contents for 

8 this Act is as follows: 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•S 4246 IS

Sec. 1. Short title; table of contents. 

Sec. 2. Research with respect to menopause and mid-life women’s health. 

Sec. 3. Public health promotion and prevention. 

Sec. 4. Public health awareness, education, and outreach program on menopause and mid-life women’s health. 

Sec. 5. Training programs to improve care and treatment of menopausal symptoms. 

Sec. 6. Centers of excellence in menopause cause and mid-life women’s health. 

Sec. 7. Reporting requirement. 

Sec. 8. Coordination. 

1 SEC. 2. RESEARCH WITH RESPECT TO MENOPAUSE AND 

2 MID-LIFE WOMEN’S HEALTH. 

3 (a) NIH RESEARCH.—Part A of title IV of the Public 

4 Health Service Act (42 U.S.C. 281 et seq.) is amended 

5 by adding at the end the following: 

6 ‘‘SEC. 404P. RESEARCH WITH RESPECT TO MENOPAUSE 

7 AND MID-LIFE WOMEN’S HEALTH. 

8 ‘‘(a) RESEARCH AND INNOVATION.— 

9 ‘‘(1) IN GENERAL.—The Director of NIH, act10 ing through the Director of the Office of Research 

11 on Women’s Health, shall coordinate and expand re12 search activities conducted by all institutes, centers, 

13 and offices of the National Institutes of Health to 

14 develop and implement Federal research programs 

15 with respect to— 

16 ‘‘(A) the impact of the symptoms and tra17 jectories of changes across the menopausal 

18 transition and the postmenopausal period on 

19 women’s physical, mental, behavioral, and cog20 nitive health; and 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•S 4246 IS

1 ‘‘(B) the prevention of related adverse 

2 health outcomes among women during the men3 opausal transition and the postmenopausal pe4 riod. 

5 ‘‘(2) GRANTS.—In carrying out paragraph (1), 

6 the Director of NIH shall award grants to eligible 

7 entities to support— 

8 ‘‘(A) biomedical and public health research 

9 and innovation in the development of new treat10 ments and diagnostic testing services for 

11 perimenopause and acute and chronic meno12 pausal symptoms; and 

13 ‘‘(B) researchers and clinicians engaged in 

14 clinical and translational research on meno15 pause and mid-life women’s health. 

16 ‘‘(3) ELIGIBLE ENTITIES.—To be eligible to re17 ceive a grant under subsection (b), an entity shall 

18 meet such criteria as the Director of NIH may es19 tablish, and shall be— 

20 ‘‘(A) an accredited entity that offers edu21 cation to students in various health professions, 

22 such asl 

23 ‘‘(i) a teaching hospital; 

24 ‘‘(ii) an accredited school of medicine, 

25 osteopathic medicine, nursing, or pharVerDate Sep 11 2014 21:46 Jun 04, 2024 Jkt 049200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\S4246.IS S4246

ssavage on LAPJG3WLY3PROD with BILLS
4 

•S 4246 IS

1 macy, or a physician assistant training 

2 program, including a historically Black col3 lege or university (as defined by the term 

4 ‘part B institution’ in section 322 of the 

5 Higher Education Act of 1965 or described 

6 in section 326(e)(1) of the Higher Edu7 cation Act of 1965) or other minority-serv8 ing institutions (as described in section 

9 371(a) of the Higher Education Act of 

10 1965)); 

11 ‘‘(iii) a certified behavioral health clin12 ic with an accredited medical or nursing 

13 residency program; 

14 ‘‘(iv) an accredited public or nonprofit 

15 private hospital with an accredited medical 

16 or nursing residency program; 

17 ‘‘(v) an accredited nurse practitioner 

18 residency program that includes and ac19 credited nursing residency program; or 

20 ‘‘(vi) a related accredited program en21 gaged in the care, treatment, or manage22 ment of menopausal symptoms; 

23 ‘‘(B) an academic research institution or 

24 other nonprofit research institution; 

25 ‘‘(C) a small business; or 


ssavage on LAPJG3WLY3PROD with BILLS
5 

•S 4246 IS

1 ‘‘(D) such other entity as the Director of 

2 NIH may determine appropriate. 

3 ‘‘(b) RESEARCH, CONDITION, AND DISEASE CAT4 EGORIZATION.—The Director of NIH shall designate, in 

5 the Research, Condition, and Disease Categorization, new 

6 categories for chronic or debilitating conditions among 

7 women, to analyze and coordinate current and future re8 search on menopause, menopausal symptoms, and short9 term and long-term effects of such symptoms on mid-life 

10 women’s health. 

11 ‘‘(c) COORDINATION.—The Director of the NIH shall 

12 coordinate and expand Federal research programs and ac13 tivities to study acute and chronic menopausal symptoms, 

14 including— 

15 ‘‘(1) vasomotor symptoms; 

16 ‘‘(2) osteoporosis; 

17 ‘‘(3) sarcopenia; 

18 ‘‘(4) temporomandibular disorders; 

19 ‘‘(5) joint and nerve pain; 

20 ‘‘(6) trauma, anxiety, depression, mood dis21 orders, and related mental and behavioral health 

22 conditions; 

23 ‘‘(7) short-term memory loss; 

24 ‘‘(8) genitourinary conditions; 

25 ‘‘(9) alopecia; 


ssavage on LAPJG3WLY3PROD with BILLS
6 

•S 4246 IS

1 ‘‘(10) vision or hearing impairments; 

2 ‘‘(11) digestive and metabolic disorders; 

3 ‘‘(12) chronic sleep deficiency, insomnia, and 

4 related sleep disorders; and 

5 ‘‘(13) other menopausal symptoms and related 

6 conditions, as the Director of NIH determines ap7 propriate. 

8 ‘‘(d) TRANSLATIONAL RESEARCH.—The Secretary 

9 shall expand translational research activities to accelerate 

10 translation of Federal research on perimenopause and 

11 menopausal symptoms and facilitate equitable delivery of 

12 perimenopause and menopause care and related mid-life 

13 women’s health services. 

14 ‘‘(e) OUTREACH AND ENGAGEMENT.—The Secretary 

15 shall expand outreach and engagement activities with ac16 credited schools of medicine, institutions of higher edu17 cation, and research institutions to support Federal re18 search activities with respect to menopausal symptoms.’’. 

19 (b) PUBLIC HEALTH RESEARCH AND DATA REPORT20 ING ACTIVITIES.—Part A of title III of the Public Health 

21 Service Act (42 U.S.C. 241 et seq.) is amended by adding 

22 at the end the following: 


ssavage on LAPJG3WLY3PROD with BILLS
7 

•S 4246 IS

1 ‘‘SEC. 310C. RESEARCH RELATING TO MID-LIFE WOMEN’S 

2 HEALTH. 

3 ‘‘(a) PUBLIC HEALTH RESEARCH.—The Secretary 

4 shall expand research activities with respect to the severity 

5 and duration of menopausal symptoms and related chronic 

6 conditions affecting mid-life health outcomes among 

7 women, including mental and behavioral health outcomes. 

8 In carrying out activities under this section, the Secretary 

9 shall coordinate with existing programs and activities of 

10 the Department of Health and Human Services. 

11 ‘‘(b) HEALTH CARE QUALITY RESEARCH.—The Sec12 retary shall expand research, program evaluation, and 

13 quality improvement activities to improve health care de14 livery for the care, treatment, or management of 

15 perimenopause and menopausal symptoms and related 

16 chronic conditions, including data collection with respect 

17 to preventive services that support mid-life health out18 comes among women and barriers to care. 

19 ‘‘(c) DASHBOARD.—The Secretary shall establish and 

20 maintain a dashboard for the reporting of data on meno21 pausal symptoms and mid-life health outcomes among 

22 women gathered through public health surveillance activi23 ties with respect to screening, testing, treatment, and pre24 vention services, and the impact of this section and section 

25 404P on such efforts. 


ssavage on LAPJG3WLY3PROD with BILLS
8 

•S 4246 IS

1 ‘‘(d) OCCUPATIONAL HEALTH RESEARCH.—The Sec2 retary shall conduct research activities and expand data 

3 collection with respect to workplace stressors related to se4 vere acute or chronic menopausal symptoms, physical in5 jury, or other adverse health outcomes among women, in6 cluding traumatic stress, anxiety, depression, and related 

7 mental and behavioral health conditions. The Secretary 

8 shall review existing evidence, identify gaps in services, 

9 and develop evidence-informed recommendations for re10 lated public health interventions and support services. 

11 ‘‘(e) INTERAGENCY COORDINATION.—The Secretary 

12 shall develop and implement new interagency research ini13 tiatives or programs to address menopausal symptoms.’’. 

14 (c) AUTHORIZATION OF APPROPRIATIONS.—For the 

15 purpose of carrying out sections 404P and 310C of the 

16 Public Health Service Act, as added by subsections (a) 

17 and (b), respectively, there are authorized to be appro18 priated $25,000,000 for each of fiscal years 2025 through 

19 2029. 

20 SEC. 3. PUBLIC HEALTH PROMOTION AND PREVENTION. 

21 Title III of the Public Health Service Act (42 U.S.C. 

22 241 et seq.) is amended by adding at the end the fol23 lowing: 


ssavage on LAPJG3WLY3PROD with BILLS
9 

•S 4246 IS

1 ‘‘PART W—ACTIVITIES TO PROMOTE MID-LIFE 

2 WOMEN’S HEALTH 

3 ‘‘SEC. 399OO. PUBLIC HEALTH PROMOTION ACTIVITIES. 

4 ‘‘(a) CHRONIC CONDITIONS AND PUBLIC HEALTH

5 PROMOTION.—The Secretary shall expand public health 

6 promotion and prevention activities with respect to mid7 life women’s health and chronic conditions, including dia8 betes, hypertension, heart disease, iron-deficiency anemia, 

9 inflammation, fibroids, endometriosis, and other related 

10 conditions and adverse health outcomes, at the discretion 

11 of the Secretary. 

12 ‘‘(b) EARLY DETECTION, DIAGNOSIS, AND TREAT13 MENT.— 

14 ‘‘(1) IN GENERAL.—The Secretary shall award 

15 grants to eligible entities to improve the early detec16 tion, diagnosis, and treatment of perimenopause and 

17 menopausal symptoms and support public health ac18 tivities to expand access to quality care services and 

19 improve mid-life health outcomes among women. 

20 ‘‘(2) ELIGIBLE ENTITIES.—To be eligible to re21 ceive a grant under paragraph (1), an entity shalll 

22 ‘‘(A) be— 

23 ‘‘(i) a State, local, Tribal, or terri24 torial public health department; 


ssavage on LAPJG3WLY3PROD with BILLS
10 

•S 4246 IS

1 ‘‘(ii) an accredited entity that offers 

2 education to students in various health 

3 professions; or 

4 ‘‘(iii) such other type of entity, as the 

5 Secretary determines appropriate; and 

6 ‘‘(B) submit an application to the Sec7 retary at such time, in such manner, and con8 taining such information as the Secretary may 

9 require. 

10 ‘‘(c) CARE COORDINATION.—The Secretary shall 

11 award grants to eligible entities described in subsection 

12 (b)(2) to support care coordination and care planning ac13 tivities, including such activities otherwise supported 

14 under this Act, and expand access to quality primary care 

15 and specialty care services to improve— 

16 ‘‘(1) mid-life women’s health, including activi17 ties to support the integration of primary care and 

18 specialty care; 

19 ‘‘(2) bone health and muscle loss; 

20 ‘‘(3) mental and behavioral health care services; 

21 ‘‘(4) joint, nerve, and muscle pain prevention 

22 services; 

23 ‘‘(5) digestive and metabolic health; 

24 ‘‘(6) prevention and management of multiple 

25 chronic conditions; 


ssavage on LAPJG3WLY3PROD with BILLS
11 

•S 4246 IS

1 ‘‘(7) physical therapy and injury prevention 

2 support services for populations affected by acute 

3 and chronic menopausal symptoms; and 

4 ‘‘(8) other services that address acute and 

5 chronic conditions that affect women’s health in 

6 perimenopause and menopause. 

7 ‘‘(d) MENTAL HEALTH AND SUBSTANCE USE PRE8 VENTION.—The Secretary shall develop recommendations 

9 and best practices to— 

10 ‘‘(1) increase access to mental and behavioral 

11 health care services and substance use disorder pre12 vention services for women experiencing 

13 perimenopause or menopausal symptoms; and 

14 ‘‘(2) expand substance use disorder treatment, 

15 recovery, and support services for women experi16 encing perimenopause, early menopause, premature 

17 menopause, and related conditions. 

18 ‘‘(e) HEALTH CARE DELIVERY.—The Secretary shall 

19 develop recommendations and best practices for— 

20 ‘‘(1) reducing disparities in the management of 

21 menopausal symptoms; 

22 ‘‘(2) improving access to perimenopause and 

23 menopause health care services; and 

24 ‘‘(3) providing patient-centered perimenopause 

25 and menopause counseling and treatment. 


ssavage on LAPJG3WLY3PROD with BILLS
12 

•S 4246 IS

1 ‘‘(f) SAFETY AND EFFECTIVENESS.—The Secretary 

2 shall carry out and support— 

3 ‘‘(1) outreach and engagement activities of the 

4 Food and Drug Administration with health care pro5 viders on perimenopause and menopause and mid6 life women’s health; 

7 ‘‘(2) oversight efforts to assess the safety and 

8 effectiveness of new diagnostic tools for 

9 perimenopause or menopausal symptoms, including 

10 devices that use artificial intelligence; and 

11 ‘‘(3) support existing activities of the Depart12 ment of Health and Human Services to enforce pri13 vacy protections for patients. 

14 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—To 

15 carry out this section, there are authorized to be appro16 priated $10,000,000 for each of fiscal years 2025 through 

17 2029.’’. 

18 SEC. 4. PUBLIC HEALTH AWARENESS, EDUCATION, AND 

19 OUTREACH PROGRAM ON MENOPAUSE AND 

20 MID-LIFE WOMEN’S HEALTH. 

21 Part W of title III of the Public Health Service Act 

22 (42 U.S.C. 241 et seq.), as added by section 3, is amended 

23 by adding at the end the following: 


ssavage on LAPJG3WLY3PROD with BILLS
13 

•S 4246 IS

1 ‘‘SEC. 399OO–1. PUBLIC HEALTH AWARENESS, EDUCATION, 

2 AND OUTREACH PROGRAM ON MENOPAUSE 

3 AND MID-LIFE WOMEN’S HEALTH. 

4 ‘‘(a) IN GENERAL.—The Secretary shall develop and 

5 carry out a national awareness, education, and outreach 

6 program relating to menopausal symptoms, mid-life wom7 en’s health, and related care, treatment, and preventive 

8 services directed at patients, health care providers, first 

9 responders (such as emergency medical service providers), 

10 and related stakeholders. Such awareness, education, and 

11 outreach program shall— 

12 ‘‘(1) disseminate educational materials and pro13 vide technical assistance for health care providers 

14 and patients to support engagement about 

15 perimenopause and menopause care and treatment 

16 options for menopausal symptoms; 

17 ‘‘(2) help such providers to identify risk factors 

18 and prevent injury among women with menopausal 

19 symptoms; and 

20 ‘‘(3) address barriers to related care and treat21 ment services for women. 

22 ‘‘(b) OUTREACH.—In carrying out this section, the 

23 Secretary shall— 

24 ‘‘(1) conduct outreach and education activities 

25 related to perimenopause and menopause and mid26 life women’s health that— 


ssavage on LAPJG3WLY3PROD with BILLS
14 

•S 4246 IS

1 ‘‘(A) include evidence-based information; 

2 and 

3 ‘‘(B) are culturally appropriate, in the case 

4 of such outreach and education activities for In5 dian Tribes; 

6 ‘‘(2) provide opportunities for State, local, Trib7 al, and territorial public health departments to cus8 tomize public health awareness, education, and out9 reach materials for their populations; and 

10 ‘‘(3) prioritize populations in areas affected by 

11 barriers to care, including rural and underserved 

12 areas. 

13 ‘‘(c) COORDINATION.—In carrying out this section, 

14 the Secretary shall coordinate with existing awareness, 

15 education, and outreach programs and activities of the De16 partment of Health and Human Services. 

17 ‘‘(d) ONLINE RESOURCES.—The Secretary shall de18 velop, operate, and maintain a website to provide edu19 cational materials in accessible formats for health care 

20 providers, patients, and caregivers, regarding 

21 perimenopause, menopause, and mid-life women’s health. 

22 Such educational materials may include— 

23 ‘‘(1) webinars, continuing education modules, 

24 videos, fact sheets, infographics, stakeholder toolkits, 


ssavage on LAPJG3WLY3PROD with BILLS
15 

•S 4246 IS

1 or other materials in formats as appropriate and ap2 plicable; and 

3 ‘‘(2) tailored for health care providers, patients, 

4 caregivers, and other audiences, as the Secretary de5 termines appropriate. 

6 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—To 

7 carry out this section, there are authorized to be appro8 priated $10,000,000 for each of fiscal years 2025 through 

9 2029.’’. 

10 SEC. 5. TRAINING PROGRAMS TO IMPROVE CARE AND 

11 TREATMENT OF MENOPAUSAL SYMPTOMS. 

12 Part D of title VII of the Public Health Service Act 

13 (42 U.S.C. 294 et seq.) is amended by inserting after sec14 tion 757 (42 U.S.C. 294f) the following: 

15 ‘‘SEC. 758. TRAINING PROGRAMS TO IMPROVE CARE AND 

16 TREATMENT OF MENOPAUSAL SYMPTOMS. 

17 ‘‘(a) GRANTS TO TRAIN HEALTH PROFESSIONALS.— 

18 ‘‘(1) IN GENERAL.—The Secretary shall award 

19 grants to eligible entities for the purpose described 

20 in paragraph (2). 

21 ‘‘(2) USE OF FUNDS.—A grant awarded under 

22 this subsection shall be used to develop, establish, or 

23 expand training programs (including accredited resi24 dency programs, fellowships, or other related clinical 

25 training) for physicians, registered nurses, nurse 


ssavage on LAPJG3WLY3PROD with BILLS
16 

•S 4246 IS

1 practitioners, physician assistants, pharmacists, 

2 other health care providers, and students and train3 ees to improve care, treatment, or management serv4 ices for perimenopause, menopausal symptoms, and 

5 related chronic conditions. 

6 ‘‘(3) ELIGIBILITY.—To be eligible to receive a 

7 grant under this subsection, an entity shall— 

8 ‘‘(A) be— 

9 ‘‘(i) an accredited school of medicine 

10 or osteopathic medicine; 

11 ‘‘(ii) an accredited nursing school; 

12 ‘‘(iii) an accredited school of phar13 macy; 

14 ‘‘(iv) an accredited public or nonprofit 

15 private hospital; 

16 ‘‘(v) an accredited medical residency 

17 program; 

18 ‘‘(vi) an accredited nurse practitioner 

19 residency program; or 

20 ‘‘(vii) a related training program for 

21 clinicians, allied health professionals, or so22 cial workers that interface with affected 

23 populations, which may include hospitals 

24 and research institutions, as determined by 

25 the Secretary; and 


ssavage on LAPJG3WLY3PROD with BILLS
17 

•S 4246 IS

1 ‘‘(B) submit an application to the Sec2 retary at such time, in such manner, and con3 taining such information as the Secretary may 

4 require. 

5 ‘‘(b) TRAINING OPPORTUNITIES.—The Secretary 

6 shall expand outreach activities to support and expand 

7 training programs, fellowships, and other opportunities for 

8 students, faculty, and trainees (including continuing med9 ical education) or establish new training opportunities to 

10 address barriers to access to— 

11 ‘‘(1) primary and specialty care services to sup12 port mid-life women’s health; and 

13 ‘‘(2) early detection, diagnosis, treatment, and 

14 care services for perimenopause, menopausal symp15 toms, and related chronic conditions. 

16 ‘‘(c) COORDINATION.—In carrying out this section, 

17 the Secretary shall coordinate with existing awareness, 

18 education, and outreach programs and activities of the De19 partment of Health and Human Services. 

20 ‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—To 

21 carry out this section there are authorized to be appro22 priated $10,000,000 for each of fiscal years 2025 through 

23 2029.’’. 


ssavage on LAPJG3WLY3PROD with BILLS
18 

•S 4246 IS

1 SEC. 6. CENTERS OF EXCELLENCE IN MENOPAUSE CAUSE 

2 AND MID-LIFE WOMEN’S HEALTH. 

3 Part W of title III of the Public Health Service Act 

4 (42 U.S.C. 241 et seq.), as amended by section 4, is fur5 ther amended by adding at the end the following: 

6 ‘‘SEC. 399OO–2. CENTERS OF EXCELLENCE IN MENOPAUSE 

7 CARE AND MID-LIFE WOMEN’S HEALTH. 

8 ‘‘(a) IN GENERAL.—The Secretary shall designate el9 igible entities as Centers of Excellence in Menopause and 

10 Mid-Life Women’s Health, and award grants to such enti11 ties, for purposes of improving professional training re12 sources for health care providers on mid-life women’s 

13 health with respect to the care, treatment, and manage14 ment of perimenopause and menopausal symptoms, and 

15 related support services. 

16 ‘‘(b) ELIGIBILITY.—To be eligible to receive a des17 ignation and grant under subsection (a), an entity shalll 

18 ‘‘(1) be an accredited entity that offers edu19 cation to students in various health professions, or 

20 such other type of entity, as the Secretary deter21 mines appropriate; 

22 ‘‘(2) demonstrate community engagement and 

23 partnerships with community stakeholders, including 

24 entities that train health professionals, social work25 ers, community health centers, health systems adVerDate Sep 11 2014 21:46 Jun 04, 2024 Jkt 049200 PO 00000 Frm 00018 Fmt 6652 Sfmt 6201 E:\BILLS\S4246.IS S4246

ssavage on LAPJG3WLY3PROD with BILLS
19 

•S 4246 IS

1 ministrators, certified behavioral health clinics, and 

2 research institutions; and 

3 ‘‘(3) submit to the Secretary an application at 

4 such time, in such manner, and containing such in5 formation as the Secretary may require. 

6 ‘‘(c) ACTIVITIES.—An entity receiving an award 

7 under subsection (a) shall develop and distribute evidence8 based resources to health care providers, patients, and 

9 public health departments regarding the care, treatment, 

10 and management of perimenopause and menopausal 

11 symptoms. Such resources may include information on— 

12 ‘‘(1) advancements in the treatment or manage13 ment of perimenopause and acute or chronic meno14 pausal symptoms; 

15 ‘‘(2) the prevention and treatment of related 

16 chronic conditions across different patient popu17 lations to support mid-life women’s health; and 

18 ‘‘(3) other topic areas that are relevant to the 

19 objectives described in subsection (a). 

20 ‘‘(d) GEOGRAPHIC DISTRIBUTION.—In awarding 

21 grants under subsection (a), the Secretary shall take into 

22 account regional differences among eligible entities and 

23 ensure equitable geographic distribution. 

24 ‘‘(e) PRIORITY.—In awarding grants under sub25 section (a), the Secretary shall prioritize eligible entities 


ssavage on LAPJG3WLY3PROD with BILLS
20 

•S 4246 IS

1 that provide services in a health professional shortage area 

2 designated under section 332 or to medically underserved 

3 populations, as defined in section 330(b)(3). 

4 ‘‘(f) EVALUATION.—Each entity receiving an award 

5 under subsection (a) shall submit an annual report to the 

6 Secretary on the activities carried out using such award. 

7 The Secretary shall evaluate each project carried out by 

8 an entity receiving an award under this section and shall 

9 report the findings with respect to each such evaluation 

10 to appropriate Federal agencies and public and private en11 tities. 

12 ‘‘(g) AUTHORIZATION OF APPROPRIATIONS.—To 

13 carry out this section, there are authorized to be appro14 priated such sums as may be necessary for each of fiscal 

15 years 2025 through 2029.’’. 

16 SEC. 7. REPORTING REQUIREMENT. 

17 (a) REPORT ON ACTIVITIES CARRIED OUT UNDER

18 THIS ACT.—Not later than 2 years after the date of enact19 ment of this Act, and every year thereafter, the Secretary 

20 of Health and Human Services shall submit to the Com21 mittee on Appropriations, the Committee on Health, Edu22 cation, Labor, and Pensions, the Committee on Finance, 

23 the Committee on Homeland Security and Government Af24 fairs, the Committee on Indian Affairs, the Committee on 

25 Veterans’ Affairs, and the Special Committee on Aging of 


ssavage on LAPJG3WLY3PROD with BILLS
21 

•S 4246 IS

1 the Senate and the Committee on Appropriations, the 

2 Committee on Energy and Commerce, the Committee on 

3 Ways and Means, the Committee on Education and the 

4 Workforce, the Committee on Veterans’ Affairs, the Com5 mittee on Natural Resources, and the Committee on Over6 sight and Accountability of the House of Representatives 

7 a report describing the progress of activities carried out 

8 under this Act and the amendments made by this Act. 

9 Each such report shall contain— 

10 (1) information with respect to Federal re11 search activities related to perimenopause and meno12 pause and mid-life women’s health, including infor13 mation related public health awareness, education, 

14 and outreach activities, including— 

15 (A) data and knowledge gaps, or other bar16 riers, related to research, diagnostic testing, 

17 and treatments with respect to perimenopause, 

18 menopause, menopausal symptoms, and related 

19 health outcomes; 

20 (B) data or information related to barriers 

21 to health care and support services among 

22 women experiencing perimenopause or meno23 pausal symptoms in rural and underserved 

24 areas; and 


ssavage on LAPJG3WLY3PROD with BILLS
22 

•S 4246 IS

1 (C) data or information related to barriers 

2 to training opportunities and resources for 

3 health care providers serving women experi4 encing perimenopause or menopausal symptoms 

5 in rural and underserved areas; 

6 (2) recommendations and best practices for 

7 health care providers and public health departments 

8 to expand access to care and increase public aware9 ness and understanding of menopausal symptoms 

10 and related chronic conditions; and 

11 (3) information about related Federal activities, 

12 as the Secretary determines appropriate. 

13 (b) REPORT ON ACCESS TO CARE AND TREAT14 MENT.—Not later than 2 years after the date of enact15 ment of this Act, the Secretary shall release a report on 

16 barriers to access to care and treatment services for 

17 perimenopause and menopausal symptoms, and rec18 ommendations to reduce any such barriers. 

19 (c) AUTHORIZATION OF APPROPRIATIONS.—To carry 

20 out this section, there are authorized to be appropriated 

21 such sums as may be necessary for each of fiscal years 

22 2025 through 2029. 

23 SEC. 8. COORDINATION. 

24 The Secretary of Health and Human Services shall 

25 coordinate activities carried out under this Act (including 


ssavage on LAPJG3WLY3PROD with BILLS
23 

•S 4246 IS

1 the amendments made by this Act) with other existing 

2 Federal efforts relating to menopausal symptoms, mid-life 

3 women’s health, aging, or public health promotion carried 

4 out by the Department of Veterans Affairs, the Depart5 ment of Defense, and other Federal departments and 

6 agencies, as appropriate. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS